Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proliferative Nephritis”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Study completedNCT00001789
What this trial is testing

BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis

Who this might be right for
Glomerulonephritis, MembranoproliferativeLupus Nephritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Testing effectiveness (Phase 2)Study completedNCT04643470
What this trial is testing

Zanubrutinib in Participants With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
BeiGene 177
Post-approval studies (Phase 4)Ended earlyNCT02226341
What this trial is testing

ACTHar in the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Columbia University 8
Large-scale testing (Phase 3)WithdrawnNCT00539799
What this trial is testing

Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
Cambridge University Hospitals NHS Foundation Trust 15
Post-approval studies (Phase 4)WithdrawnNCT01169857
What this trial is testing

Velcade for Proliferative Lupus Nephritis

Who this might be right for
Lupus NephritisProteinuriaHematuria
The Rogosin Institute
Testing effectiveness (Phase 2)Study completedNCT03095118
What this trial is testing

Daratumumab in Treatment of PGNMID and C3 GN

Who this might be right for
Membranoproliferative Glomerulonephritis
Fernando Fervenza 12
Post-approval studies (Phase 4)UnknownNCT05495893
What this trial is testing

MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN

Who this might be right for
Mycophenolate MofetilCyclophosphamideLupus Nephritis
Second Xiangya Hospital of Central South University 224
Post-approval studies (Phase 4)UnknownNCT02571842
What this trial is testing

Rituximab in Recurrent IgA Nephropathy

Who this might be right for
Recurrent IgA Nephropathy
Chulalongkorn University 30
Large-scale testing (Phase 3)Active Not RecruitingNCT07098897
What this trial is testing

To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
The Affiliated Hospital of Xuzhou Medical University 150
Testing effectiveness (Phase 2)Ended earlyNCT05097989
What this trial is testing

Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyIgAN+1 more
Alexion Pharmaceuticals, Inc. 100
Large-scale testing (Phase 3)Ended earlyNCT00430677
What this trial is testing

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Bristol-Myers Squibb 423
Testing effectiveness (Phase 2)Study completedNCT03610516
What this trial is testing

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)WithdrawnNCT05101447
What this trial is testing

Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
Children's Hospital Medical Center, Cincinnati
Testing effectiveness (Phase 2)Ended earlyNCT05540665
What this trial is testing

Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Amgen 19
Testing effectiveness (Phase 2)Study completedNCT02547922
What this trial is testing

Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
AstraZeneca 147
Post-approval studies (Phase 4)Looking for participantsNCT05207358
What this trial is testing

Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
Institutul Clinic Fundeni 30
Early research (Phase 1)Study completedNCT04128579
What this trial is testing

Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

Who this might be right for
Lupus ErythematosusLupus Nephritis
Equillium 52
Not applicableUnknownNCT03687905
What this trial is testing

Proliferative Lupus Nephritis Treatment With Chloroquine and Hydroxychloroquine

Who this might be right for
Proliferative NephritisChloroquine Retinopathy
Tanta University 60
Not applicableLooking for participantsNCT02954939
What this trial is testing

The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
The University of Hong Kong 50
Not applicableStudy completedNCT01269021
What this trial is testing

An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)

Who this might be right for
IgA Nephropathy (IgAN)
Zhi-Hong Liu, M.D. 176
Load More Results